February 24, 2026

Catalyst Pharmaceuticals, Inc. (CPRX): Strong Buy Ratings and 43% Potential Upside Propel Investor Interest

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is drawing significant attention from investors, bolstered by a robust set of buy ratings and an impressive potential upside of 43.39%...

Celldex Therapeutics (CLDX) Investor Outlook: Exploring the 119% Potential Upside in Biotech Innovation

Celldex Therapeutics, Inc. (NASDAQ: CLDX) is making waves in the biotechnology sector with its cutting-edge approach to treating severe inflammatory, allergic, and autoimmune diseases. Despite the..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: A Promising Biotech with 17.7% Upside Potential

For investors with a keen eye on the biotechnology landscape, Protagonist Therapeutics, Inc. (NASDAQ: PTGX) presents a compelling opportunity. With its roots in developing innovative peptide..

Enovis Corporation (ENOV) Stock Analysis: A Promising 101% Upside in the Healthcare Sector

Enovis Corporation (ENOV), a key player in the healthcare sector, is captivating investor attention with its potential upside of over 101%. Operating within the medical devices..

Concentra Group Holdings Parent (CON) Stock Analysis: A 22% Upside Potential with Robust Growth Metrics

Concentra Group Holdings Parent, Inc. (NASDAQ: CON), a significant player in the U.S. healthcare sector, particularly in the medical care facilities industry, presents a compelling opportunity..

GoodRx Holdings, Inc. (GDRX) Investor Outlook: Exploring a Potential 100% Upside

For investors seeking opportunities in the healthcare sector, GoodRx Holdings, Inc. (NASDAQ: GDRX) presents an intriguing case with its significant potential upside. The company, with a..

PROCEPT BioRobotics (PRCT) Stock Analysis: Unpacking the 85% Upside Potential

For investors keen on the healthcare sector, PROCEPT BioRobotics Corporation (NASDAQ: PRCT) offers a compelling opportunity. Specializing in transformative medical devices, this surgical robotics company is..

Janux Therapeutics, Inc. (JANX) Stock Analysis: Exploring a 376% Upside in Biotechnology

Janux Therapeutics, Inc. (NASDAQ: JANX), a burgeoning name in the biotechnology sector, is capturing investor attention with its pioneering approach to cancer treatment through immunotherapy. With..

CG Oncology, Inc. (CGON) Stock Analysis: Unveiling a Potential 36.95% Upside in the Biotech Sector

CG Oncology, Inc. (NASDAQ: CGON), a dynamic player in the healthcare sector, is capturing investor attention with its promising pipeline of bladder cancer therapies and an..

Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring a 31.39% Potential Upside for Savvy Investors

Bausch Health Companies Inc. (NYSE: BHC), a key player in the healthcare sector, has piqued investor interest with its diverse portfolio and substantial growth potential. Headquartered..

Envista Holdings Corporation (NVST) Stock Analysis: Navigating Growth in the Dental Market with a 15% Revenue Surge

Envista Holdings Corporation (NYSE: NVST), a prominent player in the healthcare sector, is steadily carving out its niche in the medical instruments and supplies industry. With..

Ardent Health, Inc. (ARDT) Stock Analysis: Unveiling a 34.57% Upside Potential in Healthcare

Ardent Health, Inc. (ARDT), a prominent player in the healthcare sector specializing in medical care facilities, is capturing investor attention with its promising growth potential. Based..

Schrödinger, Inc. (SDGR) Stock Analysis: Unveiling a 126.78% Potential Upside in the Healthcare Sector

For investors with an eye on the healthcare sector, Schrödinger, Inc. (NASDAQ: SDGR) presents a compelling opportunity. This New York-based company, known for its innovative use..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: A 39% Upside Potential Sparks Investor Interest

Travere Therapeutics, Inc. (NASDAQ: TVTX), a biopharmaceutical company headquartered in San Diego, California, is focused on developing therapies for rare kidney and metabolic diseases. With a..

Apellis Pharmaceuticals, Inc. (APLS) Stock Analysis: Exploring a 51% Upside Potential

For investors seeking opportunities within the biotechnology sector, Apellis Pharmaceuticals, Inc. (APLS) presents a compelling case. With a market capitalization of $2.84 billion, this Massachusetts-based company..

Ascentage Pharma Group Internat (AAPG) Stock Analysis: Potential 97.71% Upside for Patient Investors

Ascentage Pharma Group International (AAPG), a clinical-stage biotechnology company based in China, is making waves in the healthcare sector with its innovative pipeline targeting cancers and..

Select Medical Holdings Corp (SEM) Stock Analysis: Exploring a 19.35% Potential Upside

Select Medical Holdings Corporation (NYSE: SEM) operates at the intersection of healthcare innovation and patient care, providing a broad spectrum of services across critical illness recovery..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: A 28.73% Upside Potential Amidst Strong Revenue Growth

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a prominent player in the biotechnology sector, is drawing significant attention from investors with a market cap of $1.77 billion. Specializing..

BGM Group Ltd. (BGM) Stock Analysis: Navigating Uncertain Waters with Limited Analyst Insight

BGM Group Ltd. (BGM), a healthcare company entrenched in China’s dynamic pharmaceutical landscape, is catching the eye of investors with its unique product offerings. However, the..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Uncovering an 87% Potential Upside

Alphatec Holdings, Inc. (NASDAQ: ATEC) is making waves in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $1.95 billion, Alphatec..

Search

Funds

February 24, 2026

Search

Funds

February 24, 2026

FTSE 100

Funds